[Lupus erythematodes disseminatus (LED)].
D000974:Antibodies, Antinuclear / Q000032:analysis; D000917:Antibody Formation; D003165:Complement System Proteins; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D005455:Fluorescent Antibody Technique; D006801:Humans; D007104:Immune Adherence Reaction; D007136:Immunoglobulins / Q000032:analysis; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy / Q000276:immunology*; D011379:Prognosis; D012217:Rheumatoid Factor / Q000032:analysis
D000974:Antibodies, Antinuclear; D007136:Immunoglobulins; D003520:Cyclophosphamide; D003165:Complement System Proteins; D012217:Rheumatoid Factor
Lupus erythematodes disseminatus (LED.